SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

A rebound in biotech stocks is driving LABU higher, with traders tracking the sectors move through XBI and positioning around upcoming inflation data that could affect rate-sensitive biotech shares. The community is split between expecting the bounce to continue and cautioning that LABUs 3x leverage can magnify pullbacks.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires quarterly results and stepped-up share repurchases are driving discussion: some traders view the buybacks as a vote of confidence from Greg Abel, while others focus on weaker insurance performance and question whether repurchases can continue.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,366,684,616.305855 in circulation. The last known price of Stellar is 0.15346137 USD and is down -1.11 over the last 24 hours. It is currently trading on 848 active market(s) with $109,670,947.94 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLMs persistent selloff and underperformance dominate discussion, with traders warning of further losses while others treat the decline as a buying opportunity. Bulls point to Stellars tokenization and institutional-adoption prospects, including DTCC-related plans, but skeptics argue that partnerships have not translated into token demand and question the tokenomics.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture is drawing attention as traders question whether enterprise AI projects will translate into sustained consulting revenue or instead reduce billable work and pressure margins. The debate is playing out against a sharp rally and technical resistance, with bearish traders watching for a pullback and bulls pointing to insider buying and continued demand for AI implementation.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

Attention centers on long-term lorundrostat data reporting that blood-pressure benefits persisted for two years after treatment ended, alongside the upcoming FDA decision on the hypertension drug. Traders view the durability findings as encouraging but remain divided amid the stocks weakness and the binary regulatory catalyst.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Foxs acquisition of Roku has closed, ending ROKUs run as a standalone Nasdaq-listed company and shifting holders into the deals cash-and-Fox-stock consideration. The community is marking the end of the ticker with a mix of congratulations and disappointment that the sale capped Rokus potential, while some traders are also discussing bullish call activity.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

A Nasdaq and technology-sector selloff is weighing on JEPQ, prompting traders to compare its decline with the broader tech pullback. Many are buying the dip for monthly income, while others question whether distributions offset the funds price weakness and limited upside from its covered-call strategy.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus is drawing attention for the potential of its ITK inhibitor soquelitinib across several clinical indications, with traders watching for trial updates and possible partnerships. Optimists point to the science and reported institutional or insider buying, while skeptics focus on delayed data, the long path to revenue, and persistent short interest.

Invesco DB US Dollar Index Bullish Fund - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

A rebound in the U.S. dollar, with traders watching payrolls data and the Fed rate outlook, is the main focus for UUP. Some see continued dollar strength as a headwind for stocks and precious metals, while others question whether the move will last.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroups quarterly earnings dominate discussion: the bank beat expectations, yet shares fell, leaving traders debating whether higher credit-loss provisions and card-business pressure outweighed stronger results. Some view the selloff as an opportunity, while others remain concerned about costs and credit quality.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MBody AI Adds 2 Patents Pending for Its Enterprise AI Workforce Platform

Nasdaq-listed AI company MBody AI ($MBAI) files two new applications as it continues to develop and deploy Orchestrator for enterprise customers LAS VEGAS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. ("MBody AI" or the "Company") (NASDAQ: MBAI) today announced two new patent applications as...

MBody AI Brings Physical AI Robotics Platform to ThinkEquity and Maxim Investors

Nasdaq-listed physical AI company will show investors how its Orchestrator runs robots from multiple manufacturers for Fortune 500 hotel and casino operatorsLAS VEGAS, Oct. 07, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. ("MBody AI" or the "Company") (NASDAQ: MBAI) today announced that Chief Executive...

Humanoid Global Highlights MBody AI's Completion of Nasdaq Transaction and Commercial Robotics Deployment at Mohegan Sun

Vancouver, BC, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. ("Humanoid Global" or the "Company") (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in humanoid robotics and embodied...

MBody AI Presents AI Robot Workforce Platform at Lytham Fall 2026 Conference

Nasdaq-listed AI company with robot fleets in eleven U.S. states and Canada hosts CEO fireside chat September 29, with investor meetings through September 30 LAS VEGAS, Sept. 28, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. ("MBody AI" or the "Company") (NASDAQ: MBAI) today announced that Chief...

MBody AI Ltd. Completes Transformational Merger and Rebrand from Check-Cap

Check-Cap ( (MBAI) ) has shared an announcement.

On August 26, 2026, Check-Cap Ltd. completed a merger with Nevada-based MBody AI Corp., with MBody AI Corp. surviving as a wholly owned subsidiary and the combined entity rebranding as MBody AI Ltd. Former MBody AI Corp. equityholders received...

Check-Cap completes name change to MBody AI

MBody AI announced the completion of its corporate name change from Check-Cap, establishing a unified public-market identity for MBody AI following...

MBody AI Completes Name Change Following Merger and $10 Million Offering

Nasdaq-listed embodied AI company introduces its operating platform, enterprise deployments and updated market identifiersLAS VEGAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. ("MBody AI" or the "Company") (NASDAQ: MBAI) today announced the completion of its corporate name change from...

MBody AI to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Company will hold a formal presentation and one-on-one investor meetings September 14-16, 2026 ISFIYA, Israel and LAS VEGAS, Sept. 10, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. ("MBody AI" or the "Company") (NASDAQ: MBAI) today announced that John Fowler, Chief Executive Officer and Tim Hayden...

MBody AI Advances AI Robotics Rollout at Mohegan Sun

MBody AI Ltd. (NASDAQ: MBAI) completes successful Mohegan Sun pilot deployment and begins negotiation on planned commercial expansion ISFIYA, Israel and LAS VEGAS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. ("MBody AI" or the "Company") (NASDAQ: MBAI) MBody AI Ltd. (NASDAQ: MBAI) today...

MBody AI Orchestrator Named Finalist for AI Deployment of the Year

MBody AI's hardware-agnostic platform was shortlisted alongside CrowdStrike, Lenovo and CVS Health in a category recognizing real-world AI deploymentISFIYA, Israel and LAS VEGAS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. ("MBody AI" or the "Company") (NASDAQ: MBAI) today announced that its...

This account has been verified as an official MBAI representative.

Verified Account

MBody AI IR

MBody AI Ltd. designs and develops embodied artificial intelligence software for autonomous workforce and operational automation. Its flagship platform, the MBody AI Orchestrator is an AI-driven enterprise software platform that monitors, coordinates and manages robotic and sensor fleets to optimize physical work operations. Its platform provides perception AI for computer vision and environmental understanding, cognitive AI for adaptive decision-making, and learning AI for continuous on-site machine learning. Its platform also provides dynamic task and route optimization, along with fleet intelligence and coordination across multi-unit operations. The company serves the hospitality, office, warehouse, and healthcare sectors, supporting applications such as facility maintenance, workspace cleaning, autonomous logistics, inventory management, and sanitation. MBody AI Ltd. was founded in 2004 and is based in Mississauga, Canada.

MBody AI Ltd.

Penny Stock Check-Cap Has Nearly Doubled Its Value Today – What’s Going On With MBody AI Merger?

Equity

Bullish Sentiment

<ul><li>The confirmation clears a key regulatory requirement for Check-Cap advances to complete its previously announced, shareholder-approved merger with MBody AI.&nbsp;</li><li>Check-Cap in September had announced that it has entered into a merger agreement, pursuant to which Check-Cap’s subsidiary Merger Sub will merge with and into MBody AI.&nbsp;</li><li>Shareholders in November had approved the merger of Check-Cap with MBody AI.</li></ul><p>Shares of Check-Cap rallied nearly 100% on Monday after it said it has received written confirmation from the Nasdaq listing qualifications department saying that the company has regained compliance with the bourse’s rules for continued listing.</p><p>The confirmation clears a key regulatory requirement for Check-Cap advances to complete its previously announced, shareholder-approved merger with MBody AI.&nbsp;</p><h2 class="st-heading-2">MBody AI Merger</h2><p>Check-Cap in September had announced that it has entered into a merger agreement, pursuant to which Check-Cap’s subsidiary Merger Sub will merge with and into MBody AI, with MBody becoming a wholly owned subsidiary of Check-Cap.&nbsp;</p><p>Check-Cap in a regulatory filing had said that the new company will change its name from “Check-Cap, Ltd.” to “MBody AI Ltd.” or a similar name approved by the Israeli Registrar of Companies.&nbsp;</p><p>MBody AI is an emerging leader in embodied artificial intelligence, developing and actively deploying the MBody AI Orchestrator, a hardware-agnostic platform that delivers real-time data intelligence and AI-driven performance insights across robotic systems.</p><h2 class="st-heading-2">Shareholder Approval</h2><p>Shareholders in November had approved the merger of Check-Cap with MBody AI. As per a regulatory filing, 98.01% of votes cast during the annual general meeting were in favor of the merger.&nbsp;</p><p>Shareholders had also approved a reverse share split of the Check-Cap’s ordinary shares within a range of 1 for 14 to 1 for 100. The company said the exact ratio will be determined by further action of the company’s board of directors.&nbsp;</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>Retail sentiment around MBAI trended in ‘neutral’ territory amid ‘extremely low’ message volume.&nbsp;</p><p>Shares in the company have rallied more than 114% over the past 12 months.</p><p>&nbsp;</p>

Shares in Check-Cap have rallied more than 114% over the past 12 months.

Check-Cap on Monday received written confirmation from the Nasdaq listing qualifications department saying that it has regained compliance with Nasdaq’s minimum shareholders’ equity requirements.

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$2.41
Prev Close	$2.43
Open	$2.50
Dividend Yield	0.00%
50-Day Moving Average	$4.09
Beta	0.96
Avg. Volume	18,915.79
PE Ratio	0.47

52-Week High	$27.44
52-Week Low	$1.61
Market Capitalization	$36.86M
EPS (Annual)	$4.65
Price to Book	0.70
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

MBAI Fundamentals